DLCIG
XBI icon

D.L. Carlson Investment Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

D.L. Carlson Investment Group’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.52M Buy
15,924
+392
+3% +$53K 0.4% 68
2026
Q1 		$1.98M Buy
15,532
+1,230
+9% +$154K 0.34% 74
2025
Q4 		$1.74M Buy
+14,302
New +$1.64M 0.29% 76
2023
Q4 		– Sell
-94,810
Closed -$6.92M – 158
2023
Q3 		$6.92M Sell
94,810
-8,888
-9% -$710K 1.4% 20
2023
Q2 		$8.63M Buy
103,698
+153
+0.1% +$12.8K 1.65% 13
2023
Q1 		$7.89M Buy
103,545
+17,826
+21% +$1.48M 1.79% 10
2022
Q4 		$7.12M Buy
85,719
+2,387
+3% +$193K 1.53% 20
2022
Q3 		$6.61M Buy
83,332
+19,536
+31% +$1.65M 1.44% 17
2022
Q2 		$4.74M Buy
63,796
+19,685
+45% +$1.48M 1% 37
2022
Q1 		$3.96M Buy
44,111
+156
+0.4% +$14.4K 0.66% 58
2021
Q4 		$4.92M Buy
43,955
+7,054
+19% +$851K 0.79% 49
2021
Q3 		$4.64M Buy
36,901
+55
+0.1% +$7.08K 0.81% 45
2021
Q2 		$4.99M Buy
36,846
+129
+0.4% +$17K 0.86% 47
2021
Q1 		$4.98M Sell
36,717
-39,882
-52% -$5.97M 0.91% 47
2020
Q4 		$10.8M Buy
76,599
+3,469
+5% +$444K 1.96% 11
2020
Q3 		$8.15M Buy
73,130
+19,137
+35% +$2.15M 1.72% 17
2020
Q2 		$6.04M Buy
53,993
+2,740
+5% +$270K 1.8% 13
2020
Q1 		$3.97M Buy
51,253
+4,438
+9% +$393K 1.5% 17
2019
Q4 		$4.45M Buy
46,815
+943
+2% +$81.6K 1.29% 26
2019
Q3 		$3.5M Sell
45,872
-60
-0.1% -$4.99K 1.1% 34
2019
Q2 		$4.03M Sell
45,932
-5,145
-10% -$439K 1.24% 28
2019
Q1 		$4.63M Buy
51,077
+29,147
+133% +$2.48M 1.35% 23
2018
Q4 		$1.57M Sell
21,930
-19,465
-47% -$1.57M 0.52% 73
2018
Q3 		$3.97M Buy
+41,395
New +$4.01M 1.12% 36

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

D.L. Carlson Investment Group's XBI Position: Q2 2026 in Review

D.L. Carlson Investment Group increased its State Street SPDR S&P Biotech ETF (XBI) stake by 2.5% in Q2 2026, buying an estimated $53K and bringing the position to 15,924 shares worth $2.52M. The position accounts for 0.4% of the portfolio, ranked #68.

D.L. Carlson Investment Group first reported a position in XBI in Q3 2018 and has held it in 24 quarters since. The position peaked at $10.8M in Q4 2020. 936 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • D.L. Carlson Investment Group held 15,924 shares of State Street SPDR S&P Biotech ETF worth $2.52M as of Q2 2026.
  • D.L. Carlson Investment Group bought 392 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $53K.
  • State Street SPDR S&P Biotech ETF made up 0.4% of D.L. Carlson Investment Group's portfolio in Q2 2026, its #68 holding.
  • D.L. Carlson Investment Group first reported a position in State Street SPDR S&P Biotech ETF in Q3 2018 and has held it in 24 quarters since.
  • D.L. Carlson Investment Group's State Street SPDR S&P Biotech ETF position peaked at $10.8M in Q4 2020.
  • 936 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on D.L. Carlson Investment Group's 13F filing for Q2 2026, filed 11 Aug 2026.